CareCloud (MTBC) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
25 Dec, 2025Executive summary
Achieved record profitability in 2024, with GAAP net income of $7.9M, adjusted EBITDA of $24.1M (up 56%), and free cash flow of $13.2M (up 244%), despite a modest revenue decline.
Strategic focus on operational efficiency, cost-cutting, and leveraging proprietary AI technology drove margin improvements and record cash flow.
Completed a significant Series A preferred stock conversion, reducing annual dividend obligation by $7.7M, simplifying the capital structure, and aligning shareholder interests.
Fully repaid $10M credit line using internally generated cash, strengthening the balance sheet.
Re-entered the acquisition market with a small deal and plans to resume accretive acquisition strategy.
Financial highlights
FY 2024 revenue was $110.8M, down from $117.1M in 2023; Q4 2024 revenue was $28.2M, nearly flat year-over-year.
Adjusted EBITDA for FY 2024 was $24.1M, up from $15.4M in 2023; Q4 adjusted EBITDA was $7.1M, up 73% year-over-year.
Free cash flow for FY 2024 was $13.2M, compared to $3.8M in 2023; $10M used to repay line of credit.
Adjusted net income for 2024 was $10.5M ($0.65/share); Q4 adjusted net income was $3.9M ($0.24/share).
Net working capital at year-end was $5.2M, up from a deficit of $57,000 the prior year; cash balance was $5.1M.
Outlook and guidance
2025 revenue guidance: $111M–$114M, marking a return to revenue growth after prior declines.
Adjusted EBITDA projected at $26M–$28M; EPS expected between $0.10 and $0.13, first positive EPS since IPO.
Guidance assumes organic growth, small tuck-in acquisitions, and continued cost reduction efforts.
Plans to launch innovative, integrated AI solutions and resume accretive acquisition strategy.
Latest events from CareCloud
- AI-powered healthcare IT solutions drive growth, efficiency, and expanded market reach.MTBC
Investor presentation12 Mar 2026 - 2025 saw record revenue, positive EPS, and AI-driven growth, with strong 2026 outlook.MTBC
Q4 202512 Mar 2026 - First positive GAAP net income since 2022, with strong EBITDA and free cash flow growth.MTBC
Q2 20241 Feb 2026 - Record free cash flow and profitability support dividend resumption and margin growth.MTBC
Q3 202415 Jan 2026 - AI-driven healthcare platform achieves record free cash flow and resumes strategic acquisitions.MTBC
15th Annual LD Micro Invitational 202524 Dec 2025 - AI Desk Agent automates 80% of patient calls, driving efficiency, savings, and rapid ROI.MTBC
Status Update18 Dec 2025 - Registering up to $250M in securities to drive healthcare tech growth and industry consolidation.MTBC
Registration Filing16 Dec 2025 - Vote proposed to increase authorized shares to 85 million, supporting growth and acquisitions.MTBC
Proxy Filing1 Dec 2025 - Shareholders to vote on aligning Series A Preferred Stock terms with Series B, including a dividend cut.MTBC
Proxy Filing1 Dec 2025